2m 2m 2m 2m 2m 2m 2m
ZENAS BIOPHARMA (ZBIO)
NASDAQ
$31.14+$0.02 (+0.05%)
Price as of Sep 11, 2026 7:30 PM EDT- $2.0BMarket Cap
- 53.83%1-Year Change
- BiotechnologyIndustry
ZENAS BIOPHARMA (ZBIO)
$31.14+$0.02 (+0.05%)
ZBIO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $31.12 | ||
Change | +$0.02 (+0.06%) | ||
Open | $31.48 | ||
High | $32.31 | ||
Low | $31.12 | ||
Previous Close | $31.10 | ||
Volume | 421,700 | ||
30-Day Average Volume | 693,305 | ||
1-Week Change | -5.35% | ||
1-Month Change | -4.07% | ||
1-Year Change | 53.83% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 65.2M | ||
Total Assets | $701.7M | ||
Market Cap | $2.0B | ||
Enterprise Value | $2.1B | ||
Period: QTR TTM FY | |||
Revenue | $1.0M | ||
Net Income | -$111.5M | ||
Free Cash Flow | -$57.2M | ||
EBIT | -$109.6M | ||
EBITDA | -$109.6M | ||
Net Working Capital | $588.0M | ||
EPS | -$1.77 | ||
Enterprise Value/EBITDA | -19 | ||
Enterprise Value/Revenue | 2,129 | ||
P/B | 8 | ||
P/E | -18 | ||
PEG | 1 | ||
Price/Free Cash Flow | -35 | ||
Price/Operating Cash Flow | -35 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 12/24/2019 | ||
Last Split Factor | 1 : 2 | ||
Last Split Date | 05/24/2018 | ||
Earnings & Revenue